Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Osteoporosis 1Lung Neoplasms 1Humoral Hypercalcemia Of Malignancy 1Hematologic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1

Interventions

parathyroid hormone-related peptide (1-36) 2Zoledronic Acid 2Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Humoral Hypercalcemia Of Malignancy × Ibandronic Acid × Clear all
NCT00326820 2013-03-13

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Wales Cancer Trials Unit

Phase 3 Unknown
1,404 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡